PCD Pharma Franchise Opportunities in Sikkim with Daksh Diabetes and Cardiac Care
Recent health data reveals that Sikkim has the highest proportion of hypertension among all Indian states, with prevalence significantly exceeding national averages of 16.2% for men and 10.7% for women. Analysis from the National Family Health Survey shows that the highest prevalence of prehypertension is also recorded in Sikkim, indicating a large population already at risk of developing full-blown hypertension.
The burden of diabetes is equally concerning, with the state emerging as a hotspot for non-communicable diseases. A quality improvement study conducted in West Sikkim found that among 4,323 outpatient attendees aged 30 years and above, 35% were screened for diabetes and 12% were newly diagnosed with the condition. Screening coverage varied widely across facilities, ranging from just 9% to 100%, while the yield of new diagnoses varied from 0% to 36%. These figures point to substantial gaps in detection and the need for improved screening across the state.
The primary drivers include Sikkim’s unique dietary patterns rich in high glycemic index foods like rice and wheat-based preparations, high saturated fat from cooking oils and meat, and sugar-rich sweets combined with sedentary occupations, stressful urban living in Gangtok and other towns, declining physical activity, and lifestyle changes associated with urbanization. A comprehensive health report also highlights a shortage of medical specialists, particularly in oncology and neurology, forcing residents to seek treatment outside the state and incurring substantial financial strain.
The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Sikkim families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes.
How Daksh is making a Difference in Sikkim
1. Affordable, Quality-Assured Medications
Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment.
What this means for Sikkim patients:
- Access to WHO-GMP certified medications
- Lower out-of-pocket expenses for lifelong treatments
- No compromise on quality despite affordable pricing
2. Complete Cardiac Care Portfolio
Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs:
| Product Category | Daksh Offerings | Purpose |
| ACE Inhibitors | DORAPIL (Ramipril) | Blood pressure control, heart failure treatment |
| ARBs | CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) | Hypertension management |
| Beta-Blockers | CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) | Heart rate control, heart failure |
| Calcium Channel Blockers | DUPIN (Amlodipine), CLINITAC (Cilnidipine) | Blood pressure, angina |
| Diuretics | TORDAC (Torsemide), FRUSIDIP | Fluid management in heart failure |
| Lipid Management | ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) | Cholesterol control |
3. Complete Diabetic Care Portfolio
For diabetes management, Daksh provides modern therapeutic options including:
| Product Category | Daksh Offerings |
| SGLT2 Inhibitors | DYFOZIN (Dapagliflozin) the modern heart-protective diabetes drug |
| DPP-4 Inhibitors | TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) |
| Sulfonylureas | GLIMIDAC (Glimepiride) |
| Biguanides | GLYCODIP SR (Metformin) |
| Combination Therapies | DYFOZIN M, GLIMIDAC MV (triple combination) |
4. Focus on Preventive Care
Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications:
- Liver tonics for medication-induced liver protection
- Calcium supplements for bone health (critical for diabetic patients)
- Vitamin complexes for overall metabolic support
5. Supporting Healthcare Providers across Sikkim
Daksh works with hospitals, clinics, and pharmacies across Sikkim to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses.
With the state’s high disease burden and growing pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. Sikkim offers low competition in rural and semi-urban areas, making it an attractive market for new franchise businesses. Major locations for pharma franchise opportunities include Gangtok, Namchi, Mangan, Geyzing, Singtam, Rangpo, and Jorethang.
Popular Locations for PCD Pharma Franchise in Sikkim
| PCD / Franchise Keywords | Product / Therapy Keywords |
| PCD pharma franchise in Gangtok | Cardiac diabetic PCD company in Gangtok |
| PCD pharma franchise in Namchi | Cardiac diabetic products in Namchi |
| PCD pharma franchise in Mangan | Diabetic cardiac PCD franchise in Mangan |
| PCD pharma franchise in Geyzing | Cardiac diabetic PCD company in Geyzing |
| PCD pharma franchise in Singtam | Cardiac diabetic products in Singtam |
| PCD pharma franchise in Rangpo | Diabetic cardiac PCD franchise in Rangpo |
| PCD pharma franchise in Jorethang | Cardiac diabetic PCD company in Jorethang |
| PCD pharma franchise in Pakyong | Cardiac diabetic products in Pakyong |
| PCD pharma franchise in Ravangla | Diabetic cardiac PCD franchise in Ravangla |
| PCD pharma franchise in Yuksom | Cardiac diabetic PCD company in Yuksom |
Conclusion
The diabetes and heart disease burden in Sikkim is not just a statistic it is a reality affecting thousands of families. With the state recording the highest proportion of hypertension among all Indian states, a diabetes screening yield of 12% among newly diagnosed patients, and significant gaps in healthcare access, the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives.
Daksh Diabetic & Cardiac Care is committed to being part of this solution providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines.
Contact Daksh Diabetic and Cardiac
| Contact Method | Details |
| Office Address | Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India |
| Phone | 📞 +91 93565 60523 📞 +91 78886 02869 |
| enquirypurchase.daksh@gmail.com | |
| Contact us | https://diabetes-cardiac.com/contact-us/ |